Breast cancer patients, survivors, caregivers and supporters marched from Central Park to Times Square, calling for greater visibility and continued investment in metastatic breast cancer research.
NEW YORK, NY (October, 2026) — Cancer Culture took its message directly to the streets of Manhattan, bringing together breast cancer patients, survivors, caregivers and supporters for a powerful advocacy march from Central Park to Times Square, calling for greater visibility and continued investment in life-saving metastatic breast cancer research.
The demonstration brought together both women and men affected by breast cancer, highlighting a reality too often absent from mainstream awareness campaigns: breast cancer does not affect one gender, one age, or one type of person.
Also worth a look: Maximizing Non-Profit Funding: Executive Q&A With Nicole Spracale, COO and Integrator at Fox Advancement and Modernizing Contract Lifecycle Management: Matthew Solé on Transforming Legal Agreements into Strategic Assets.
Moving through the heart of Manhattan before arriving in Times Square, participants carried their stories into one of the world’s most visible public spaces—turning deeply personal experiences with diagnosis, treatment, survivorship and metastatic disease into a collective call for action.
BEYOND AWARENESS
As Breast Cancer Awareness Month brings renewed attention to the disease this October, Cancer Culture is challenging the conversation to move beyond awareness alone.
For people living with metastatic breast cancer, the need for new treatments, greater research investment, and increased visibility exists every day of the year.
“Awareness matters, but awareness alone isn’t enough,” said Beth Love of Cancer Culture. “For people living with metastatic breast cancer, this isn’t a month or a campaign—it is their life. We are here to make sure their voices are seen, their stories are heard and research remains part of the conversation.”
At the center of the march were the patients themselves.
Rather than speaking for people affected by breast cancer, Cancer Culture created a platform for patients to speak for themselves—bringing their experiences directly into the public eye and putting faces and stories behind a disease too often reduced to statistics.
The participation of men affected by breast cancer also challenged one of the disease’s persistent misconceptions and reinforced the need for a more inclusive conversation around diagnosis, awareness and research.
A CALL FOR RESEARCH, VISIBILITY AND ACTION
Cancer Culture’s Times Square activation is part of the organization’s broader mission to change how breast cancer is discussed, represented and understood.
By bringing patients, survivors, caregivers, and supporters together in one of the world’s most recognizable public spaces, the organization sought to make one message impossible to overlook:
Breast cancer patients need more than awareness. They need research, representation, and continued investment in treatments that can extend and save lives.
Cancer Culture directs 100% of proceeds from its fundraising efforts to metastatic breast cancer research, helping support the scientific work needed to improve outcomes for people living with the disease.
As October brings renewed national attention to breast cancer, Cancer Culture is asking the public to look beyond the pink ribbon and listen to the people whose lives are directly affected. Go to www.cancerculture.org to donate or see how you can support this inspiring organization.
ABOUT CANCER CULTURE
Cancer Culture is a patient-led nonprofit and multimedia movement dedicated to transforming the conversation surrounding breast cancer through storytelling, advocacy, photography, film, and live experiences.
By centering the voices of people living with breast cancer—particularly those living with metastatic disease—Cancer Culture challenges outdated narratives while advocating for greater visibility, support, and increased research funding.
Cancer Culture directs 100% of proceeds from its fundraising efforts to metastatic breast cancer research.